TrialClinical drug investigation2014

Cost effectiveness of adding dapagliflozin to insulin for the treatment of type 2 diabetes mellitus in the Netherlands.

Heleen G M van Haalen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.